Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 06, 2017 01:00 ET | Source: TiGenix

TiGenix kondigt gedeeltelijke conversie van obligaties aan

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PERSBERICHT TiGenix kondigt...
November 02, 2017 02:00 ET | Source: TiGenix

TiGenix strengthens European IP protection around lead development program Cx601

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE TiGenix strengthens...
November 02, 2017 02:00 ET | Source: TiGenix

TiGenix versterkt de Europese IP-bescherming voor het ontwikkelingsprogramma Cx601

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PERSBERICHT TiGenix versterkt de...
November 02, 2017 02:00 ET | Source: TiGenix

TiGenix renforce la protection intellectuelle en Europe pour le programme de développement du Cx601

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUÉ DE PRESSE TiGenix...
October 31, 2017 02:00 ET | Source: TiGenix

TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE TiGenix provides...
October 23, 2017 01:00 ET | Source: TiGenix

La FDA américaine accorde à TiGenix l'appellation de médicament orphelin pour le Cx601

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUÉ DE PRESSE La FDA américaine...
October 23, 2017 01:00 ET | Source: TiGenix

Cx601 van TiGenix door de Amerikaanse FDA aangewezen als weesgeneesmiddel

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PERSBERICHT Cx601 van TiGenix door de...
October 23, 2017 01:00 ET | Source: TiGenix

TiGenix granted Orphan Drug Designation from the U.S. FDA for Cx601

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE TiGenix granted Orphan...
October 05, 2017 01:00 ET | Source: TiGenix

TiGenix présentera les résultats favorables de la semaine 52 de l'essai de phase III de Cx601 à l'occasion du Congrès Mondial de Gastro-entérologie à ACG 2017

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} COMMUNIQUÉ DE PRESSE TiGenix...
October 05, 2017 01:00 ET | Source: TiGenix

TiGenix to present positive 52-week Phase III results of Cx601 at World Congress of Gastroenterology at ACG 2017 meeting

body { font-family: Arial, Verdana, Helvetica; font-size: 13px;} table.hugin { border-color:black;} td.hugin { padding: 3px; border-color:black;} PRESS RELEASE TiGenix to present...